Beta-glucuronidase enzyme blends for drug analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing drugs in biological samples using beta-glucuronidase enzymes face challenges due to the variability of enzyme activity across different substrates and conditions, such as pH and temperature, leading to inefficiencies and contamination issues with crude enzyme preparations.

Innovation Solution

Development of enzyme blends comprising highly purified beta-glucuronidase enzymes from different sources, optimized to exhibit synergistic activity across a range of substrates and conditions, enhancing the enzyme's utility and specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If crude enzyme preparations are used, then the enzyme source is simple and cost-effective, but the enzyme activity is variable and contaminated with other substances

Engineering Contradiction:
Improveease of enzyme preparationVSAvoidenzyme activity consistency
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent segments the enzyme preparation process into multiple purification stages (chromatography, filtration, centrifugation) to separate the beta-glucuronidase enzyme from contaminants in crude preparations, achieving both purity and consistent activity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent optimizes enzyme activity by carefully controlling pH levels (7.0-9.0) and temperature (20-40°C) during the enzymatic reaction, transforming the unreliable crude enzyme performance into consistent and reproducible results

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If a single beta-glucuronidase enzyme is used, then the enzyme preparation is simple, but the enzymatic activity varies across different substrates and conditions

Engineering Contradiction:
Improveenzyme preparation complexityVSAvoidsubstrate range coverage
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple beta-glucuronidase enzymes from different sources (bacterial, fungal, plant) into a synergistic blend that collectively hydrolyzes a broader spectrum of substrates including opiates, benzodiazepines, and other drugs, overcoming the limited substrate specificity of individual enzymes

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The enzyme blend is designed to perform multiple functions by hydrolyzing diverse glucuronide substrates across different chemical classes, making it a universal tool for detecting various drugs in biological samples rather than being specialized for a single substrate type

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If highly purified enzyme preparations are used, then the enzyme activity is high and specific, but the preparation process becomes complex and costly

Engineering Contradiction:
Improveenzyme activity and specificityVSAvoidenzyme preparation process
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple purification techniques (chromatography, filtration, centrifugation) into an integrated preparation process that efficiently produces high-purity enzyme blends without requiring excessively complex procedures, balancing purity with process simplicity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent establishes optimal reaction conditions (pH 7.0-9.0, temperature 20-40°C, substrate concentration ratios) that maximize enzyme activity and specificity while maintaining practical laboratory conditions, ensuring high reliability without requiring extreme parameter values

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The enzyme blends demonstrate increased activity and specificity, overcoming the limitations of single enzyme preparations by achieving synergistic effects, thereby improving the efficiency and reliability of drug analysis in clinical and forensic applications.

Implementation Method 1

The beta-glucuronidase (BGUS) enzyme catalyzes the hydrolysis of a wide variety of beta-glucuronides

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

Beta-glucuronidases (BGUS; EC 3.2.1.31) hydrolyze the beta-glycosidic bond between the anomeric reducing end of glucuronic acid (GlcU or gluc) and a broad range of possible aglycones

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Data Source

PatentUS11807879B2Compositions of beta-glucuronidase enzyme blends with enhanced enzymatic activity and methods of preparation thereof
Publication Date: 2023.11.07 INTEGRATED MICRO CHROMATOGRAPHY SYST INC
  • US11807879B2 patent drawing
  • US11807879B2 patent drawing
  • US11807879B2 patent drawing

AI summary

Blends of enzymes of the same enzyme class (same EC number), such as beta-glucuronidase enzyme blends, are provided that exhibit synergistic levels of activity across a range of substrates as compared to the activity levels of each enzyme in the blend individually. The blends also may exhibit a greater effective substrate range, as well as greater effective pH and/or temperature ranges as compared to single enzyme preparations. Predictive methods for determining optimal enzyme blends, methods for preparing enzyme blends, enzyme blend compositions, enzyme blend formulations and methods of using such enzyme blends are provided.